K
Kiera L. Clayton
Researcher at Ragon Institute of MGH, MIT and Harvard
Publications - 26
Citations - 2229
Kiera L. Clayton is an academic researcher from Ragon Institute of MGH, MIT and Harvard. The author has contributed to research in topics: Cytotoxic T cell & T cell. The author has an hindex of 18, co-authored 24 publications receiving 1523 citations. Previous affiliations of Kiera L. Clayton include Massachusetts Institute of Technology & University of Toronto.
Papers
More filters
Journal ArticleDOI
COVID-19-neutralizing antibodies predict disease severity and survival.
Wilfredo F. Garcia-Beltran,Evan C. Lam,Michael G Astudillo,Diane Yang,Tyler E. Miller,Jared Feldman,Blake M. Hauser,Timothy M. Caradonna,Kiera L. Clayton,Adam Nitido,Mandakolathur R. Murali,Galit Alter,Richelle C. Charles,Anand S. Dighe,John A. Branda,Jochen K. Lennerz,Daniel Lingwood,Aaron G. Schmidt,A. John Iafrate,Alejandro B. Balazs +19 more
TL;DR: It is found that severe cases resulting in intubation or death exhibited increased inflammatory markers, lymphopenia, pro-inflammatory cytokines, and high anti-receptor binding domain (RBD) antibody levels, highlighting the importance of neutralizing humoral immunity on disease progression and the need to develop broadly protective interventions to prevent future coronavirus pandemics.
Journal ArticleDOI
CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
Yu-Hwa Huang,Chen Zhu,Yasuyuki Kondo,Ana C. Anderson,Amit Gandhi,Andrew Russell,Stephanie K. Dougan,Britt-Sabina Petersen,Espen Melum,Thomas Pertel,Kiera L. Clayton,Monika Raab,Qiang Chen,Nicole Beauchemin,Paul J. Yazaki,Michal Pyzik,Mario A. Ostrowski,Jonathan N. Glickman,Christopher E. Rudd,Hidde L. Ploegh,Andre Franke,Gregory A. Petsko,Vijay K. Kuchroo,Richard S. Blumberg +23 more
TL;DR: In this article, the authors showed that CEACAM1 facilitates the maturation and cell surface expression of TIM-3 by forming a heterodimeric interaction in cis through the highly related membrane-distal N-terminal domains of each molecule.
Journal ArticleDOI
TIGIT Marks Exhausted T Cells, Correlates with Disease Progression, and Serves as a Target for Immune Restoration in HIV and SIV Infection.
Glen M. Chew,Tsuyoshi Fujita,Tsuyoshi Fujita,Gabriela M. Webb,Benjamin J. Burwitz,Benjamin J. Burwitz,Helen L. Wu,Jason S. Reed,Katherine B. Hammond,Kiera L. Clayton,Naoto Ishii,Mohamed Abdel-Mohsen,Teri Liegler,Brooks I. Mitchell,Frederick Hecht,Mario A. Ostrowski,Cecilia M. Shikuma,Scott G. Hansen,Scott G. Hansen,Mark Maurer,Alan J. Korman,Steven G. Deeks,Jonah B. Sacha,Jonah B. Sacha,Lishomwa C. Ndhlovu +24 more
TL;DR: TIGIT is identified as a novel marker of dysfunctional HIV-specific T cells and suggest TIGIT along with other checkpoint receptors may be novel curative HIV targets to reverse T cell exhaustion.
Journal ArticleDOI
HCV‐specific T cells in HCV/HIV co‐infection show elevated frequencies of dual Tim‐3/PD‐1 expression that correlate with liver disease progression
Bahareh Vali,R. Brad Jones,Ali Sakhdari,Prameet M. Sheth,Kiera L. Clayton,Feng-Yun Yue,Gabor Gyenes,David Wong,Marina B. Klein,Sahar Saeed,Erika Benko,Colin Kovacs,Rupert Kaul,Rupert Kaul,Mario A. Ostrowski,Mario A. Ostrowski +15 more
TL;DR: It is demonstrated that co‐expression of Tim‐3 and PD‐1 may play a significant role in HCV‐specific T‐cell dysfunction, especially in the setting of HIV co‐infection.
Journal ArticleDOI
Resistance of HIV-infected macrophages to CD8+ T lymphocyte-mediated killing drives activation of the immune system.
Kiera L. Clayton,David R. Collins,David R. Collins,Josh Lengieza,Musie Ghebremichael,Farokh Dotiwala,Farokh Dotiwala,Judy Lieberman,Judy Lieberman,Bruce D. Walker,Bruce D. Walker,Bruce D. Walker +11 more
TL;DR: It is demonstrated that macrophages are intrinsically resistant to CTL-mediated killing and can thereby contribute to the maintenance of HIV reservoirs and chronic inflammation.